Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. What is Letairis? Letairis is a prescription medicine used to treat pulmonary arterial hypertension (PAH), which is high blood pressure in …

Letairis (ambrisentan) is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and delay clinical worsening; and in combination …

Letairis (ambrisentan) is a prescription medicine used to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of the lungs. Why Stay With Letairis? Use …

Sep 11, 2024 · Letairis prevents thickening of the blood vessels, especially those in the lungs and heart. Ambrisentan also lowers blood pressure in your lungs, helping your heart pump blood …

Find patient medical information for Letairis oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Nov 9, 2022 · Letairis (ambrisentan) is an endothelin receptor antagonist used to treat pulmonary arterial hypertension (PAH). Letairis blocks the effects of endothelin-1, helping to decrease the …

Ambrisentan, sold under the brand name Letairis among others, is a drug used for the treatment of pulmonary hypertension. [3][5] It is an endothelin receptor antagonist. [3] The peptide …

-------------------------INDICATIONS AND USAGE------------------------------ Letairis is an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) …

Feb 12, 2025 · Letairis is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): To improve exercise ability and delay clinical worsening. In combination with …

Jan 6, 2025 · Common Letairis side effects include fluid retention, nasal congestion, and flushing. Cough, anemia, and indigestion are also possible, especially when you take Letairis with …